RNA editing enzyme ADAR2 is a mediator of neuropathic pain after peripheral nerve injury.
Uchida H, Matsumura S, Okada S, Suzuki T, Minami T, Ito S.
Uchida H, et al. Among authors: okada s.
FASEB J. 2017 May;31(5):1847-1855. doi: 10.1096/fj.201600950R. Epub 2017 Jan 26.
FASEB J. 2017.
PMID: 28126736
These findings suggest that ADAR2 is a mediator of injury-induced tactile allodynia and thus a potential therapeutic target for the treatment of neuropathic pain.-Uchida, H., Matsumura, S., Okada, S., Suzuki, T., Minami, T., Ito, S. RNA editing enzyme …
These findings suggest that ADAR2 is a mediator of injury-induced tactile allodynia and thus a potential therapeutic target for the treatmen …